Guy Jean Savoir – CEO, Carnot Laboratories
Guy Jean Savoir, CEO of family-run Mexican pharma Carnot Laboratories explains the company’s USD 150 million investment in a new facility, its plans to focus manufacturing efforts on vaccines and…
Address: Heriberto Frias #1035, Col. Del Valle, Mexico D.F.
Heriberto Frias #1035, Col. Del Valle, Mexico D.F.
Heriberto Frias #1035, Col. Del Valle, Mexico D.F.,Mexico
Tel:
Web: http://www.techsphere.com.mx/
Carnot Laboratories is a 100% Mexican company focused on high technology systems in the manufacturing of their products. The company considers the launch of innovative products and continuous product renewal the cornerstone of its growth in order to meet the current requirements of the population. Carnot’s manufacturing facilities have been certified by COFEPRIS, INVIMA, ANVISA and ANMAT and is now present all over Central and South America, with affiliates in Argentina, Peru, Colombia and Uruguay.
Carnot ® Laboratories adds value through its business philosophy, offering manufacturing in areas such as hormonal injectables, oral solids, oral liquids, semisolids, conditioning and inhaled biological products that meet national and international quality standards. Carnot products are based on years of experience and technological innovation.
Guy Jean Savoir, CEO of family-run Mexican pharma Carnot Laboratories explains the company’s USD 150 million investment in a new facility, its plans to focus manufacturing efforts on vaccines and…
Carnot is celebrating 70 years as a company. There have been a lot of changes over this time, but more specifically over the last three to four years, please can…
Victor Matos, Senior Commercial Director at Johnson & Johnson MedTech in Mexico, shares insights about his first days as a Managing Director, highlighting the importance of connecting the company’s objectives…
Patricia Nakagawa, Managing Director of Karl Storz, Mexico Caribbean and Central America, explains the German family-owned MedTech’s ongoing evolution towards a more corporate structure and the new hub status she…
Rogerio Peso outlines how Viatris leverages collaborations to address critical healthcare needs in Mexico, combining its strengths with other stakeholders to improve patient outcomes. With a mission to offer high-quality,…
With the naming of Armida Zuñiga as head of the country’s regulatory body COFEPRIS, new Mexican president Claudia Sheinbaum has concluded the new government’s healthcare appointments and begun advancing her…
Emily Morris, head of Sanofi in Latin America discusses the company’s transformative journey under the 2019-initated ‘Play to Win’ strategy. With an emphasis on optimizing their portfolio and prioritizing immunoscience,…
Monica Palomanes, General Manager of Roche Mexico, discusses her journey within the company and the shift from traditional sales to a collaborative approach with Patient Journey Partners. She addresses challenges…
Carlos Escobar highlights his extensive career journey at Baxter/Vantive, emphasizing the company’s commitment to enhancing patient care through innovative technologies in Mexico and Latin America. He discusses the shift towards…
Nicolas Linares of Ultragenyx Pharmaceutical Mexico highlights the company’s commitment to developing innovative treatments for rare and ultra-rare diseases. He emphasizes the importance of collaboration with healthcare systems and the…
Cecilia Moreno, from the PPD™ clinical research business of Thermo Fisher Scientific, highlights Mexico’s growing role in clinical research, supported by regulatory advancements and a skilled workforce. Moreno emphasizes the…
Sworn in this month as Mexico’s first female president, Claudia Sheinbaum has pledged “continuity with change,” with respect to her predecessor Andrés Manuel López Obrador’s policies. While she has promised…
Carlos Salazar, president of the National Association of Healthcare Providers (ANAPS) and director general of the association’s medical device trade event, Medical Expo, discusses ANAPS’ role in supporting the medical…
Arturo Rodriguez, CEO of Infinite Clinical Research, discusses the current state of clinical trials in Mexico and highlights the country’s unique advantages, such as a diverse population with experienced medical…
See our Cookie Privacy Policy Here
